Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T62449 | Target Info | |||
Target Name | Checkpoint kinase-1 (CHK1) | ||||
Synonyms | Serine/threonine-protein kinase Chk1; Chk1; Cell cycle checkpoint kinase; CHK1 checkpoint homolog | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CHEK1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Protein Name | Breast cancer type 1 susceptibility protein (BRCA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Biochemical Activity | [2] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Target Name | M-phase inducer phosphatase 1 (MPIP1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Dual specificity phosphatase Cdc25A; Cdc25A phosphatase | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Biochemical Activity | [4] | |||
3 | Biochemical Activity | [5] | |||
4 | Biochemical Activity | [6] | |||
5 | Biochemical Activity | [7] | |||
6 | Biochemical Activity | [8] | |||
7 | Reconstituted Complex | [9] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [10] | |||
2 | Affinity Capture-Western | [11] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | Serine/threonine-protein kinase ATR (FRP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FRAP-related protein 1; Ataxia telangiectasia and Rad3-related protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Biochemical Activity | [13] | |||
3 | Protein-peptide | [14] | |||
Interacting Target Name | ATM serine/threonine kinase (ATM) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine-protein kinase ATM; Ataxia telangiectasia mutated; A-T mutated | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [5] | |||
2 | Protein-peptide | [14] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | Herpesvirus ubiquitin-specific protease (HAUSP) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-specific-processing protease 7; Ubiquitin thioesterase 7; Ubiquitin carboxyl-terminal hydrolase 7; Herpesvirus-associated ubiquitin-specific protease; Deubiquitinating enzyme 7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Biochemical Activity | [16] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Biochemical Activity | [18] | |||
3 | Biochemical Activity | [19] | |||
4 | Co-localization | [20] | |||
Other proteins | [+] 2 Other proteins | + | |||
Interacting Protein Name | Claspin (CLSPN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Affinity Capture-Western | [22] | |||
3 | Affinity Capture-Western | [23] | |||
4 | Biochemical Activity | [24] | |||
5 | Reconstituted Complex | [21] | |||
6 | Reconstituted Complex | [24] | |||
Interacting Protein Name | DNA damage-binding protein 1 (DDB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DDBA; UV.DDB1; XAP1; XPCE; XPE; XPE.BF | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [25] | |||
2 | Affinity Capture-Western | [25] | |||
3 | Affinity Capture-Western | [22] | |||
4 | Affinity Capture-Western | [26] | |||
5 | Affinity Capture-Western | [27] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet. 2002 Mar;30(3):285-9. | ||||
REF 2 | Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J. 2007 Apr 18;26(8):2083-93. | ||||
REF 3 | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. Mol Cell Proteomics. 2016 Sep;15(9):3030-44. | ||||
REF 4 | Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science. 1997 Sep 5;277(5331):1497-501. | ||||
REF 5 | Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell. 2003 Mar;3(3):247-58. | ||||
REF 6 | Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14795-800. | ||||
REF 7 | Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase. J Biol Chem. 2008 Jul 11;283(28):19322-8. | ||||
REF 8 | Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint. J Biol Chem. 2003 Aug 8;278(32):29824-9. | ||||
REF 9 | Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint. Cell Cycle. 2003 Sep-Oct;2(5):473-8. | ||||
REF 10 | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012 Aug 31;150(5):987-1001. | ||||
REF 11 | Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage. Mol Cancer Ther. 2011 Jul;10(7):1194-206. | ||||
REF 12 | Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J. 2005 Mar 23;24(6):1157-69. | ||||
REF 13 | Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress. Oncogene. 2009 May 7;28(18):1971-81. | ||||
REF 14 | Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem. 1999 Dec 31;274(53):37538-43. | ||||
REF 15 | USP7 regulates the stability and function of HLTF through deubiquitination. J Cell Biochem. 2011 Dec;112(12):3856-62. | ||||
REF 16 | ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014 Sep;16(9):864-75. | ||||
REF 17 | Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways. Neoplasia. 2002 Mar-Apr;4(2):171-80. | ||||
REF 18 | Regulatory interactions between the checkpoint kinase Chk1 and the proteins of the DNA-dependent protein kinase complex. J Biol Chem. 2003 Aug 8;278(32):29940-7. | ||||
REF 19 | The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000 Feb 1;14(3):289-300. | ||||
REF 20 | Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J Cell Biol. 2004 Sep 13;166(6):801-13. | ||||
REF 21 | Human claspin is required for replication checkpoint control. J Biol Chem. 2003 Aug 8;278(32):30057-62. | ||||
REF 22 | CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol. 2013 Jan;33(2):213-26. | ||||
REF 23 | Cleavage of claspin by caspase-7 during apoptosis inhibits the Chk1 pathway. J Biol Chem. 2005 Oct 21;280(42):35337-45. | ||||
REF 24 | Repeated phosphopeptide motifs in human Claspin are phosphorylated by Chk1 and mediate Claspin function. J Biol Chem. 2006 Nov 3;281(44):33276-82. | ||||
REF 25 | DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res. 2009 Mar 15;69(6):2630-7. | ||||
REF 26 | The DNA repair component Metnase regulates Chk1 stability. Cell Div. 2014 Jul 9;9:1. | ||||
REF 27 | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. Oncogene. 2017 Jun 29;36(26):3740-3748. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.